 OncoSec Medical Incorporated the Company or OncoSec Nasdaq: ONCS, a company developing late-stage intratumoral cancer immunotherapies, today announced the Company will be featured in a live webinar, Grand Rounds: A Webinar in Biotech and Specialty Pharma, hosted by James Molloy, Managing Director of Equity Research, Biotechnology and Specialty Pharmaceuticals at Alliance Global Partners, on Monday, July 13, 2020 at 10:30 a.m. Eastern Time. 